Search This Blog

Tuesday, April 22, 2014

Novartis acquisition adds 'tremendous value'

GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.

http://video.cnbc.com/gallery/?video=3000269291

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.